• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Making the case: developing innovative adherence solutions for the treatment of tuberculosis.

作者信息

Verma Malvika, Furin Jennifer, Langer Robert, Traverso Giovanni

机构信息

Department of Biological Engineering and Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.

Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA.

出版信息

BMJ Glob Health. 2019 Feb 1;4(1):e001323. doi: 10.1136/bmjgh-2018-001323. eCollection 2019.

DOI:10.1136/bmjgh-2018-001323
PMID:30815283
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6361324/
Abstract
摘要

相似文献

1
Making the case: developing innovative adherence solutions for the treatment of tuberculosis.论证理由：开发用于治疗结核病的创新性依从性解决方案。
BMJ Glob Health. 2019 Feb 1;4(1):e001323. doi: 10.1136/bmjgh-2018-001323. eCollection 2019.
2
A gastric resident drug delivery system for prolonged gram-level dosing of tuberculosis treatment.用于延长结核病治疗中革兰氏级剂量的胃驻留药物递送系统。
Sci Transl Med. 2019 Mar 13;11(483). doi: 10.1126/scitranslmed.aau6267.
3
People-centered tuberculosis care versus standard directly observed therapy: study protocol for a cluster randomized controlled trial.以患者为中心的结核病护理与标准直接观察治疗：一项整群随机对照试验的研究方案
Trials. 2015 Jun 22;16:281. doi: 10.1186/s13063-015-0802-2.
4
Drones and digital adherence monitoring for community-based tuberculosis control in remote Madagascar: A cost-effectiveness analysis.基于无人机和数字依从性监测的马达加斯加偏远地区结核病控制：成本效益分析。
PLoS One. 2020 Jul 7;15(7):e0235572. doi: 10.1371/journal.pone.0235572. eCollection 2020.
5
Adherence to treatment for latent tuberculosis infection: systematic review of studies in the US and Canada.潜伏性结核感染治疗的依从性：美国和加拿大研究的系统评价
Int J Tuberc Lung Dis. 2008 Nov;12(11):1235-54.
6
Adherence to tuberculosis preventive therapy among HIV-infected persons in Chiang Rai, Thailand.泰国清莱地区艾滋病毒感染者对结核病预防性治疗的依从性。
AIDS. 1997 Jan;11(1):107-12. doi: 10.1097/00002030-199701000-00016.
7
Drug adherence and efficacy of smear microscopy in the diagnosis of pulmonary tuberculosis after 2 months of medication in North-western Tanzania.坦桑尼亚西北部地区患者服药 2 个月后，药物依从性与痰涂片镜检对肺结核诊断的效果。
Int J Infect Dis. 2017 Oct;63:43-47. doi: 10.1016/j.ijid.2017.07.025. Epub 2017 Aug 3.
8
The prevalence and factors associated for anti-tuberculosis treatment non-adherence among pulmonary tuberculosis patients in public health care facilities in South Ethiopia: a cross-sectional study.埃塞俄比亚南部公共卫生保健机构中肺结核患者抗结核治疗不依从性的患病率及相关因素：一项横断面研究
BMC Public Health. 2017 Mar 20;17(1):269. doi: 10.1186/s12889-017-4188-9.
9
Strategies to Promote Adherence to Treatment by Pulmonary Tuberculosis Patients: A systematic review.促进肺结核患者坚持治疗的策略：一项系统综述。
JBI Libr Syst Rev. 2012;10(11):615-678. doi: 10.11124/jbisrir-2012-64.
10
Tuberculosis in the community: 1. Evaluation of a volunteer health worker programme to enhance adherence to anti-tuberculosis treatment.社区中的结核病：1. 对一项旨在提高抗结核治疗依从性的志愿者卫生工作者项目的评估。
Tuber Lung Dis. 1996 Jun;77(3):274-9. doi: 10.1016/s0962-8479(96)90013-1.

引用本文的文献

1
Advanced drug delivery and therapeutic strategies for tuberculosis treatment.用于结核病治疗的先进药物输送和治疗策略。
J Nanobiotechnology. 2023 Nov 9;21(1):414. doi: 10.1186/s12951-023-02156-y.
2
Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems.克服患者依从性障碍：开发创新药物传递系统的案例。
Nat Rev Drug Discov. 2023 May;22(5):387-409. doi: 10.1038/s41573-023-00670-0. Epub 2023 Mar 27.
3
Pediatric Tuberculosis Management: A Global Challenge or Breakthrough?儿童结核病管理：全球挑战还是突破？
Children (Basel). 2022 Jul 27;9(8):1120. doi: 10.3390/children9081120.
4
Engineered drug delivery devices to address Global Health challenges.用于应对全球健康挑战的工程药物输送装置。
J Control Release. 2021 Mar 10;331:503-514. doi: 10.1016/j.jconrel.2021.01.035. Epub 2021 Jan 28.
5
Development of a long-acting direct-acting antiviral system for hepatitis C virus treatment in swine.开发长效直接作用抗病毒系统治疗猪丙型肝炎病毒。
Proc Natl Acad Sci U S A. 2020 Jun 2;117(22):11987-11994. doi: 10.1073/pnas.2004746117. Epub 2020 May 18.
6
Nano-based anti-tubercular drug delivery: an emerging paradigm for improved therapeutic intervention.基于纳米的抗结核药物传递：改善治疗干预的新兴范例。
Drug Deliv Transl Res. 2020 Aug;10(4):1111-1121. doi: 10.1007/s13346-020-00786-5.
7
Hydrogels For Peptide Hormones Delivery: Therapeutic And Tissue Engineering Applications.用于肽类激素递送的水凝胶：治疗及组织工程应用
Drug Des Devel Ther. 2019 Sep 26;13:3405-3418. doi: 10.2147/DDDT.S217211. eCollection 2019.

本文引用的文献

1
Optimizing the immunogenicity of HIV prime-boost DNA-MVA-rgp140/GLA vaccines in a phase II randomized factorial trial design.在一项 II 期随机析因试验设计中优化 HIV 初免-加强型 DNA-MVA-rgp140/GLA 疫苗的免疫原性。
PLoS One. 2018 Nov 29;13(11):e0206838. doi: 10.1371/journal.pone.0206838. eCollection 2018.
2
Ultra-long-acting removable drug delivery system for HIV treatment and prevention.长效可移除型 HIV 治疗与预防药物输送系统。
Nat Commun. 2018 Oct 8;9(1):4156. doi: 10.1038/s41467-018-06490-w.
3
Drug-resistant tuberculosis: will grand promises fail children and adolescents?耐药结核病：宏伟的承诺会让儿童和青少年失望吗？
Lancet Child Adolesc Health. 2018 Apr;2(4):237-238. doi: 10.1016/S2352-4642(18)30068-3. Epub 2018 Mar 13.
4
Transcutaneously refillable nanofluidic implant achieves sustained level of tenofovir diphosphate for HIV pre-exposure prophylaxis.经皮可再填充纳米流控植入物实现了替诺福韦二磷酸酯的持续水平，用于 HIV 暴露前预防。
J Control Release. 2018 Sep 28;286:315-325. doi: 10.1016/j.jconrel.2018.08.010. Epub 2018 Aug 6.
5
Formulation of Natural Oil Nano-Emulsions for the Topical Delivery of Clofazimine, Artemisone and Decoquinate.天然油纳米乳剂的配方用于氯法齐明、青蒿琥酯和地克珠利的局部递送。
Pharm Res. 2018 Aug 7;35(10):186. doi: 10.1007/s11095-018-2471-9.
6
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis.长效注射用阿托伐醌纳米药物用于疟疾预防。
Nat Commun. 2018 Jan 22;9(1):315. doi: 10.1038/s41467-017-02603-z.
7
Development of an oral once-weekly drug delivery system for HIV antiretroviral therapy.用于HIV抗逆转录病毒疗法的口服每周一次给药系统的研发。
Nat Commun. 2018 Jan 9;9(1):2. doi: 10.1038/s41467-017-02294-6.
8
Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial.长效肌内注射卡替拉韦和利匹韦林治疗成人 HIV-1 感染（LATTE-2）：一项随机、开放标签、2b 期、非劣效性试验的 96 周结果。
Lancet. 2017 Sep 23;390(10101):1499-1510. doi: 10.1016/S0140-6736(17)31917-7. Epub 2017 Jul 24.
9
Intrathecal Isoniazid for Refractory Tuberculous Meningitis with Cerebral Infarction.鞘内注射异烟肼治疗难治性结核性脑膜炎合并脑梗死
Intern Med. 2017;56(8):953-957. doi: 10.2169/internalmedicine.56.6945. Epub 2017 Apr 15.
10
Oral, ultra-long-lasting drug delivery: Application toward malaria elimination goals.口服、超长效药物输送：在消除疟疾目标方面的应用。
Sci Transl Med. 2016 Nov 16;8(365):365ra157. doi: 10.1126/scitranslmed.aag2374.